MPHC:QSEMesaieed Petrochemical Holding Company Q.S.C. Analysis
Data as of 2026-03-15 - not real-time
QAR 1.04
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
MPHC is trading at QAR 1.04, well above its DCF‑derived fair value of QAR 0.57, indicating a material overvaluation. The stock carries a trailing P/E of 25.9 versus a forward P/E of just 6.1, a dividend yield of 4.09% that is backed by a payout ratio of 133% (suggesting unsustainable dividend payments), and a stark revenue decline of 89% year‑over‑year. Operating cash flow is negative while free cash flow remains positive, and the company has no debt, but low ROE (3.3%) and ROA (2.0%) point to limited profitability.
Technically, the 20‑day SMA (1.054) sits below the 50‑day (1.080) and 200‑day (1.227) averages, confirming a bearish trend, while the RSI at 44.5 signals neutral momentum. The MACD line turned bullish recently, though the histogram is marginal, and volume is increasing. The price is near the identified support of QAR 0.98 and below the resistance of QAR 1.113. Low beta (~0.18) implies limited market‑wide volatility, yet the 30‑day volatility is high at 27.5% and the max drawdown reaches 30%. Market sentiment is in “Greed” mode (fear‑greed index 72.9), but analyst coverage is absent.
Technically, the 20‑day SMA (1.054) sits below the 50‑day (1.080) and 200‑day (1.227) averages, confirming a bearish trend, while the RSI at 44.5 signals neutral momentum. The MACD line turned bullish recently, though the histogram is marginal, and volume is increasing. The price is near the identified support of QAR 0.98 and below the resistance of QAR 1.113. Low beta (~0.18) implies limited market‑wide volatility, yet the 30‑day volatility is high at 27.5% and the max drawdown reaches 30%. Market sentiment is in “Greed” mode (fear‑greed index 72.9), but analyst coverage is absent.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price significantly above DCF fair value
- Bearish SMA alignment confirming downtrend
- Dividend payout ratio exceeds 100%, raising sustainability concerns
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential correction toward fair value levels
- Low beta reduces exposure to broader market swings
- Strong cash reserves offset operating cash flow weakness
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Fundamental overvaluation persists without clear growth catalyst
- Cyclical nature of the chemicals sector adds uncertainty
- Lack of analyst coverage limits forward guidance confidence
Key Metrics & Analysis
Financial Health
Revenue Growth-88.90%
Profit Margin96.99%
P/E Ratio25.9
ROE3.27%
ROA2.00%
P/B Ratio0.8
Op. Cash FlowQAR-29080000
Free Cash FlowQAR339.2M
Technical Analysis
TrendBearish
RSI44.5
SupportQAR 0.98
ResistanceQAR 1.11
MA 20QAR 1.05
MA 50QAR 1.08
MA 200QAR 1.23
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueQAR 0.57
GradeOvervalued
TypeValue
Dividend Yield4.09%
Risk Assessment
Beta0.18
Volatility27.53%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.